← Back

Shanghai Kingstar Winning Software

Winning Health Technology Group Co., Ltd. provides digital health services for medical and health institutions in China through itself and its subsidiaries. Its offerings include the WiNEX digital health platform, internet and health care, smart hospital, smart regional healthcare, and WinCloud solutions, which are used in smart hospitals, regional health, public health, medical insurance, health services, and other fields. The company is also involved in software development, information system operation and maintenance, investment, non-residential real estate leasing, technology development, transfer, and promotion, and medical device sale, as well as computer hardware, software, and peripherals, information technology consulting, internet data, technical consulting, and technical services. Formerly known as Shanghai Kingstar Winning Software Co., Ltd., it changed its name to Winning Health Technology Group Co., Ltd. in January 2016, was founded in 1994, and is headquartered in Shanghai, China.

Country
Price · split & dividend adjusted
News & notes moving 300253.CS
300253.CS2

Winning Health Technology's 2026 interim report shows net loss of 176 million yuan, widening year-on-year

Winning Health Technology released its 2026 interim report. Total operating revenue was 994 million yuan, and net profit attributable to the parent company was negative 176 million yuan, a decrease of 58.43 million yuan compared with the same period last year, with the loss widening. Net cash inflow from operating activities was 15.09 million yuan, down 71.95 percent year-on-year. The company's asset-liability ratio was 33.29 percent, gross margin was 33.67 percent, return on equity was negative 3.22 percent, and diluted earnings per share was negative 0.08 yuan. The number of shareholders was 112,900, and the top ten shareholders held 30.49 percent of total share capital.
Jiemian·24dRead more →
300253.CS

Winning Health Technology posts first-half loss of 176 million yuan, rating outlook revised to negative

Winning Health Technology disclosed its 2026 interim report, with operating revenue of 994 million yuan for the period, up 18.50 percent year on year, but net loss attributable to shareholders of the parent company was 176 million yuan, wider than the 118 million yuan loss in the same period last year. The weaker performance was mainly due to large impairment losses on contract assets and accounts receivable totaling more than 117 million yuan, while higher research and development and sales spending and investment losses from associates also dragged on profit. By product, software and services revenue was 828 million yuan, up 16.55 percent year on year; systems integration revenue was 67.35 million yuan, a slight increase of 1.73 percent; and internet healthcare revenue was 99.15 million yuan, surging 58.32 percent as a bright spot, though the low-margin integration business weighed on the overall structure. Selling expenses were 153 million yuan, up 26.03 percent year on year; administrative expenses were 115 million yuan, up 43.32 percent; and research and development expenses were 172 million yuan, up 38.71 percent, with higher staff pay the main reason. Among shareholders, director Jin Mao reduced holdings by 1.2236 million shares, and chief financial officer Wang Li reduced holdings by 282,500 shares, while actual controllers Zhou Wei and Wang Ying kept their holdings unchanged. Zhou Wei was previously sentenced for the crime of unit bribery, and the company and Zhou Wei received warning letters and public reprimands. The credit rating of the company and its convertible bonds remains AA, but the rating outlook has been revised to negative.
南方财经网·24dRead more →